2502 Organometallics, Vol. 21, No. 12, 2002
Barrio et al.
(both s, PCHCH3), 18.4 (s, NCCH3). 1H NMR (300 MHz, C7D8,
233 K): δ 7.5-6.8 (m, 10H, Ph), 2.56 and 2.50 (both s, 3H,
NCCH3), 2.30 (m, 6H, PCH), 1.96 (s, 6H, NC(CH3)2), 1.81 (s,
6H, PCH), 1.2-1.1 (m, 72H, PCHCH3), 0.32 and 0.30 (both br
s, OsdCdCH), -7.97 and -8.70 (both t, J P-H ) 16.6 Hz, 1H,
OsH). 31P{1H} NMR (121.42 MHz, C7D8, 233 K): δ 23.8 and
23.0 (both s). 13C{1H} NMR (75.42 MHz, C7D8, 233 K): δ_286.3
(t, J C-P ) 9.8 Hz, OsdC), 285.7 (t, J C-P ) 8.3 Hz, OsdC), 140.1
and 140.0 (both s, NdC), 134.6 and 133.7 (both s, CipsoPh),
122.8, 122.1, 121.4, and 121.3 (all s, Ph), 108.8 and 108.2 (both
s, OsdCdCHPh), 25.1 (vt, N ) 23.5 Hz, PCH), 23.8 (vt, N )
22.6 Hz, PCH), 22.7 (s, NCCH3), 20.2, 19.5, and 19.4 (all s,
PCHCH3), 18.3, 18.0, and 16.6 (all s, NCCH3). MS (FAB+): m/z
687 (M+).
P r ep a r a tion of [OsH{F ---HONdC(CH3)2}(tCCH2P h )-
(P iP r 3)2]BF 4 (10). A lilac solution of 4 (142 mg, 0.183 mmol)
in 12 mL of dichloromethane was treated with HBF4‚Et2O (30
µL, 0.220 mmol) and stirred for 2.5 h at room temperature
and then was filtered through Celite and evaporated to
dryness. Subsequent addition of dichloromethane (0.5 mL) and
diethyl ether (5 mL) caused the precipitation of a lilac solid,
which was washed with further portions of diethyl ether and
dried in vacuo. Yield: 90 mg (62%). Anal. Calcd for C27H61
-
BF5NOOsP2: C 41.91; H 7.95; N 1.81. Found: C 41.57; H 7.78;
N 2.0. IR (KBr, cm-1): ν(OH) 3210 (br), ν(OsH) 2174 (m), ν(CN)
1
1580 (s), ν(BF) 1050 (br). H NMR (300 MHz, CD2Cl2, 293 K):
δ 11.59 (d, J F-H ) 67.5 Hz, 1H, OH), 7.4-7.1 (m, 5H, Ph), 2.88
(br, 2H, OstCCH2), 2.49 and 2.32 (both s, 3H, NCCH3), 2.31
The protonation of complex 7 (15 mg, 0.022 mmol) in 0.5
mL of CD2Cl2 (1H NMR) or CH2Cl2 (2H NMR) in NMR tubes
with the stoichiometric amount of DBF4‚D2O (3 µL, 0.022
mmol) gives the complex [OsH{κ-N,κ-O[ONdC(CH3)2]}-
(tCCH2Ph)(PiPr3)2]BF4 with the CâH2 group partially deuter-
ated. After 10 min the 1H NMR spectrum indicates that the
protonation is quantitative. 2H NMR (46.03 MHz, CH2Cl2, 293
K): δ 2.89 (br, 1.7D, CD2Ph).
P r ep a r a tion of OsH{K-N,K-O[ONdC(CH3)2]}(dCdCH-
Cy)(P iP r 3)2 (8). This complex was prepared as described for
7 starting from 5 (83 mg, 0.106 mmol) and a solution of KOH
in methanol (1.1 mL, 0.212 mmol, 0.1888 N). A brown oil was
obtained. Yield: 30.0 mg (41%). IR (Nujol, cm-1): ν(OsH) 2091
(m), ν(CN) 1631 (s). 1H NMR (300 MHz, C6D6, 293 K, plus
hetcor): δ 2.65 (m, 6H, PCH), 2.6-0.9 (m, 11H, Cy), 2.10 and
1.98 (both s, 3H, NC(CH3)2), 1.42 and 1.36 (both dvt, N ) 12.9
Hz, J H-H ) 6.6 Hz, 18H, PCHCH3), 0.98 (s, 1H, OsdCdCH),
-8.49 (t, J H-P ) 17.4 Hz, 1H, OsH). 31P{1H} NMR (121.42
MHz, C6D6, 293 K): δ 22.26 (s). 13C{1H} NMR (75.42 MHz,
C6D6, 293 K, plus dept): δ 284.7 (t, J C-P ) 9.8 Hz, OsdC),
138.7 (s, NdC), 110.0 (s, OsdCdCHCy), 30.0 (s, primary
carbon atom of the cyclohexyl group), 38.4, 27.3, and 26.8 (all
s, secondary carbon atoms of the cyclohexyl group), 24.4 (vt,
N ) 23.3 Hz, PCH), 22.3 (s, NCCH3), 20.1 and 19.8 (both s,
PCHCH3), 18.1 (s, NCCH3). MS (FAB+): m/z 694 (M+ + H).
(m, 6H, PCH), 1.29 and 1.25 (both dvt, N ) 14.4 Hz, J H-H
)
7.2 Hz, 18H, PCHCH3), -6.66 (td, J P-H ) 16.5 Hz, J F-H ) 6.9
Hz, 1H, OsH). 31P{1H} NMR (121.42 MHz, CD2Cl2, 293 K): δ
36.62 (d, J F-P ) 39.0 Hz). 19F NMR (282.33 MHz, CD2Cl2, 293
K): δ -263.9 (dtd, J F-H ) 67.5 Hz, J F-P ) 39.0 Hz, J F-H ) 6.9
Hz, OsF), -154.6 (s, BF4). 13C{1H} NMR (75.42 MHz, CD2Cl2,
293 K, plus dept): δ 277.9 (dt, J C-F ) 109.5 Hz, J C-P ) 9.2
Hz, OstC), 163.3 (s, NdC), 129.9 and 129.6 (both s, Ph), 129.1
(s, CparaPh), 127.4 (s, CipsoPh), 57.9 (d, J C-F ) 11.5 Hz,
OstCCH2), 26.0 (s, NCCH3), 25.4 (vt, N ) 26.2 Hz, PCH), 19.8
(s, NCCH3), 19.1 and 18.7 (both s, PCHCH3). MS (FAB+): m/z
689 (M+ - F).
P r ep a r a tion of [OsH{F ---DONdC(CH3)2}(tCCH2P h )-
(P iP r 3)2]BF 4 (10-d 1). To solutions of 4 (15 mg, 0.019 mmol)
in 0.5 mL of CD2Cl2 (1H NMR) or CH2Cl2 (2H NMR) in NMR
tubes was added the stoichiometric amount of DBF4‚D2O (2.5
mL, 0.019 mmol). After 10 min the 1H NMR spectrum indicates
the quantitative formation of 10-d 1. 2H NMR (46.03 MHz, CH2-
Cl2, 293 K): δ 11.90 (d, J D-F ) 10 Hz, OD).
P r ep a r a tion of [OsH{F ---HONdC(CH3)2}(tCCH2Cy)-
(P iP r 3)2]BF 4 (11). This complex was prepared as described
for 10 starting from 116 mg (0.148 mmol) of 5 and HBF4‚Et2O
(24 µL, 0.178 mmol). A white solid was obtained. Yield: 102
mg (86%). Anal. Calcd for C29H63BF5NOOsP2: C 43.55; H 7.94;
N 1.75. Found: C 43.08; H 7.81; N 1.96. IR (KBr, cm-1): ν(OH)
3186 (br), ν(OsH) 2183 (m), ν(CN) 1654 (s), ν(BF) 1050 (br).
1H NMR (300 MHz, CD2Cl2, 293 K): δ 11.68 (d, J F-H ) 68.1
Hz, 1H, OH), 3.5-0.9 (m, 11H, Cy), 2.47 (m, 6H, PCH), 2.43
and 2.32 (both s, 3H, NCCH3), 1.54 (br, 2H, OstCCH2), 1.35
and 1.34 (both dvt, N ) 14.2 Hz, J H-H ) 7.0 Hz, 18H,
PCHCH3), -6.98 (td, J P-H ) 17.1 Hz, J F-H ) 6.6 Hz, 1H, OsH).
31P{1H} NMR (121.42 MHz, CD2Cl2, 293 K): δ 35.90 (d, J F-P
) 38.1 Hz). 19F NMR (282.33 MHz, CD2Cl2, 293 K): δ -265.9
(dtd, J F-H ) 68.1 Hz, J F-P ) 38.1 Hz, J F-H ) 6.6 Hz, OsF),
-155.2 (s, BF4). 13C{1H} NMR (75.42 MHz, CD2Cl2, 293 K, plus
dept): δ 283.9 (dt, J C-F ) 109.1 Hz, J C-P ) 8.7 Hz, OstC),
163.3 (s, NdC), 59.3 (d, J C-F ) 10.6 Hz, OstCCH2), 35.2
(s, primary carbon atom of the cyclohexyl group), 33.6, 25.8,
and 25.6 (all s, secondary carbon atoms of the cyclohexyl
group), 25.6 (vt, N ) 24.4 Hz, PCH), 25.4 and 19.9 (both s,
NCCH3), 19.3 and 18.7 (both s, PCHCH3). MS (FAB+): m/z
694 (M+ - HF).
P r ep a r a tion of OsH{K-N,K-O[ONdC(CH3)2]}(dCdCH-
tBu )(P iP r 3)2 (9). This complex was prepared as described for
7 starting from 6 (210 mg, 0.279 mmol) and a solution of KOH
in methanol (2.9 mL, 0.558 mmol, 0.1888 N). A yellow solid
was obtained. Yield: 90.0 mg (48%). Anal. Calcd for C27H59
-
NOOsP2: C 48.70; H 8.93; N 2.10. Found: C 48.35; H 8.67; N
2.28. IR (KBr, cm-1): ν(OsH) 2080 (m), ν(CN) 1628 (s). 1H NMR
(300 MHz, C6D6, 293 K, plus hetcor): δ 2.67 (m, 6H, PCH),
2.11 and 2.01 (both s, 3H, NCCH3), 1.43 (dvt, N ) 12.7 Hz,
J H-H ) 6.6 Hz, 18H, PCHCH3), 1.41 (s, 9H, C(CH3)3), 1.34 (dvt,
N ) 12.7 Hz, J H-H ) 6.6 Hz, 18H, PCHCH3), 0.71 (s, 1H, Osd
CdCH), -8.70 (t, J H-P ) 17.3 Hz, 1H, OsH). 31P{1H} NMR
(121.42 MHz, C6D6, 293 K): δ 20.65 (s). 13C{1H} NMR (75.42
MHz, C6D6, 293 K, plus apt): δ 284.1 (t, J C-P ) 8.3 Hz, Osd
C), 139.1 (s, NdC), 115.9 (s, OsdCdCHtBu), 33.7 (s, C(CH3)3),
24.6 (s, C(CH3)3), 24.4 (vt, N ) 23.0 Hz, PCH), 22.4 (s, NCCH3),
20.3 and 19.9 (both s, PCHCH3), 18.4 (s, NCCH3). 1H NMR
(300 MHz, C7D8, 218 K): δ 2.55 and 2.47 (both m, 6H, PCH),
2.00 (s, 6H, NC(CH3)2), 1.94 and 1.79 (both s, 3H, NCCH3),
1.39 (s, 9H, C(CH3)3) 1.4-1.1 (m, 72H, PCHCH3), 1.2 (s, 9H,
C(CH3)3), 1.41 (s, 9H, C(CH3)3), 0.71 and 0.66 (both s, 1H, Osd
P r ep a r a tion of [OsH{F ---HONdC(CH3)2}(tCCH2tBu )-
(P iP r 3)2]BF 4 (12). This complex was prepared as described
for 10 starting from 115 mg (0.152 mmol) of 6 and HBF4‚Et2O
(25 µL, 0.183 mmol). A white solid was obtained.Yield: 55.9
mg (66%). Anal. Calcd for C27H61BF5NOOsP2: C 41.91; H 7.95;
N 1.81. Found: C 41.57; H 7.78; N 2.00. IR (KBr, cm-1): ν(OH)
3218 (br), ν(OsH) 2176 (m), ν(CN) 1578 (s), ν(BF) 1050 (br).
1H NMR (300 MHz, CD2Cl2, 293 K): δ 11.64 (d, J F-H ) 68.7
Hz, 1H, OH), 2.48 (m, 6H, PCH), 2.45 and 2.32 (both s, 3H,
NCCH3), 1.69 (br, 2H, OstCCH2), 1.35 (dvt, N ) 14.1 Hz, J H-H
) 7.0 Hz, 36H, PCHCH3), 1.04 (s, 9H, C(CH3)3), -7.07 (td, J P-H
) 18.0 Hz, J F-H ) 6.6 Hz, 1H, OsH). 31P{1H} NMR (121.42
MHz, CD2Cl2, 293 K): δ 33.97 (d, J F-P ) 39.0 Hz). 19F NMR
CdCH), -8.49 (t, J H-P ) 16.5 Hz, 1H, OsH), -8.96 (t, J H-P
)
18.0 Hz, 1H, OsH). 31P{1H} NMR (121.42 MHz, C7D8, 218 K):
δ 21.5 and 18.4 (both s). 13C{1H} NMR (75.42 MHz, C7D8, 218
K): δ 284.2 (t, J C-P ) 10.5 Hz, OsdC), 283.6 (t, J C-P ) 7.9 Hz,
OsdC),139.3 and 139.1 (both s, NdC), 116.2 and 114.5 (both
s, OsdC)CHtBu), 33.8 and 33.5 (both s, C(CH3)3), 24.9 and
24.6 (both s, C(CH3)3), 24.4 and 23.9 (both vt, N ) 26.3 Hz,
PCH), 22.9 and 22.5 (both s, NCCH3), 20.3, 19.6, and 19.1 (all
s, PCHCH3), 18.3 and 17.9 (both s, NCCH3). MS (FAB+): m/z
668 (M+ + H).